Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. G.N. (Gert) Moll

prof. dr. G.N. (Gert) Moll

Honorary professor Protein Modification and Functionality

Publicaties

Advances in the therapeutic potentials of ligands of the apelin receptor APJ

Clinical significance of intervention in the renin-angiotensin-aldosterone-apelinergic system

Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer

AT2 receptor agonist LP2 restores respiratory function in a rat model of bleomycin-induced lung remodelling

Evolving views on the first two ligands of the angiotensin II type 2 receptor. From putative antagonists to potential agonists?

Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma

LP2, a cyclic angiotensin-(1−7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice

LP2, a stable lanthipeptide derived from cAng-(1-7), exerts myeloprotective action in mice

Intranasal Delivery of a Methyllanthionine-Stabilized Galanin Receptor-2-Selective Agonist Reduces Acute Food Intake

LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study

Pers/media

Uit RUG voortgekomen Lanthio Pharma Chemische Start-up van het Jaar